v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:          
Net loss     $ (2,246) $ (10,608)  
Adjustments to reconcile net loss to cash used in operating activities:          
Impairment of long-lived assets - held for sale     293    
Impairment of intangible assets     111   $ 68
Amortization and depreciation     694 762  
Amortization of right-of-use asset     206 189  
Other non-cash gains     (32) (947)  
Provision for credit losses     507 4  
(Gain) loss on sale or disposal of property, plant, and equipment     (12) 65  
Debt related charges included in interest expense     1,586 1,906  
Equity-based compensation     225 233  
Change in fair value of warrant liabilities     207 (424)  
Change in fair value of derivative liability       (482)  
Change in inventory reserves     (215) 431  
Changes in operating assets and liabilities:          
Accounts receivable     (1,301) (117)  
Inventories     (676) 1,575  
Prepaid expenses and other assets     (1,610) 284  
Insurance recoveries     (9,500)    
Accounts payable     (672) (466)  
Accrued expenses     1,012 (509)  
Accrued payroll     (178) (700)  
Accrued excise taxes and fees     1,361 (75)  
Other liabilities     (232) (1,068)  
Net cash used in operating activities     (10,472) (9,947)  
Cash flows from investing activities:          
Acquisition of patents, trademarks, and licenses     (75)    
Acquisition of property, plant and equipment     (45) (141)  
Proceeds from the sale of property, plant and equipment     770 22  
Issuance of 2025 GVB promissory note     (500)    
Net cash provided by (used in) investing activities     150 (119)  
Cash flows from financing activities:          
Payments on notes payable     (909) (1,231)  
Proceeds from issuance of notes payable     1,023 1,256  
Payments of penalties from long-term debt     (28)    
Payments of long-term debt $ (1,017)   (4,308) (670)  
Net proceeds from warrant exercise     5,075 3,403  
Net proceeds from Series A preferred stock     9,893    
Payment of common stock issuance costs       (324)  
Taxes paid related to net share settlement of RSUs       (1)  
Net cash provided by financing activities     10,746 13,349  
Net increase in cash and cash equivalents     424 3,283  
Cash and cash equivalents - beginning of period   $ 4,422 4,422 2,058 2,058
Cash and cash equivalents - end of period $ 4,846   4,846 5,341 $ 4,422
Non-cash transactions:          
Capital expenditures incurred but not yet paid     621 8  
Deemed dividends       7,711  
Stock issued in connection with settled indebtedness     500 1,617  
Non-cash licensing arrangement     230 100  
Right-of-use assets and corresponding operating lease obligations     (666)    
Equity issuance costs accrued but not yet paid       537  
Stock issued for extinguishment of Subordinated Note       3,864  
Payment of 2023 GVB promissory note     500 1,500  
Payment of debt issuance costs       603  
Equity conversion of Senior Secured Credit Facility     3,132 2,481  
Equity subscription receivable       37  
Insurance recoveries release     768    
Conversion option remeasurement   $ 283 $ 283    
Registered Direct Offering          
Cash flows from financing activities:          
Proceeds from issuance of common stock       $ 10,916